Table 4 Comparison of demographic variables, frequency of associated symptoms and main phenotypic variables of the headache between males and females.

From: Frequency and phenotype of headache in covid-19: a study of 2194 patients

Variable

Entire study sample (n = 458)

Males (n = 128)

Females (n = 330)

FDR adjusted P value

Median age (years)

51 (42–61)

48 (40–60)

53 (43–62)

0.05

Prior history of headache

223/449 (49.7%)

50/128 (39.1%)

173/321 (53.9%)

0.042

Headache as the first symptom

128/446 (28.7%)

28/127 (22.0%)

100/319 (31.3%)

0.225

Duration of headache (days)

7 (IQR 4–14)

7 (IQR 4–10)

8 (IQR 4–16)

0.227

Anosmia

269/448 (60%)

81/128 (63.3%)

188/320 (58.8%)

0.705

Asthenia

337/458 (73.6%)

96/128 (75.0%)

241/330 (73.0%)

0.862

Cough

294/446 (65.9%)

93/128 (72.7%)

201/318 (63.2%)

0.254

Diarrhea

185/447 (41.4%)

54/128 (42.2%)

131/319 (41.1%)

0.905

Dyspnea

179/444 (40.3%)

53/127 (41.7%)

126/317 (39.7%)

0.850

Fever

263/444 (59.2%)

80/128 (62.5%)

183/316 (57.9%)

0.760

Myalgia

228/443 (51.5%)

67/128 (52.3%)

161/315 (51.1%)

0.905

Weakness

238/446 (53.4%)

72/128 (56.3%)

166/318 (52.2%)

0.644

Presence of pneumonia

152/450 (33.8%)

50/127 (39.4%)

102/323 (31.6%)

0.254

Need for oxygen

86/447 (19.2%)

31/126 (24.6%)

55/321 (17.1%)

0.231

Headache as the most bothersome symptom

68/428 (15.9%)

22/123 (17.9%)

46/305 (15.1%)

0.616

Median intensity (0–10 NRS)

7 (IQR 6–8)

6 (IQR 5–8)

7 (IQR 6–8)

0.002

Median impairment (0–100% NRS)

50% (IQR 20–80%)

50 (IQR 10–70)

55 (IQR 20–80)

0.055

Frontal topography

307/433 (70.9%)

87/128 (68.0%)

220/305 (72.1%)

0.652

Temporal topography

190/433 (43.9%)

52/128 (40.6%)

128/305 (45.2%)

0.662

Pressing quality

324/434 (74.7%)

93/128 (72.7%)

231/306 (75.5%)

0.684

Photophobia

152/456 (33.3%)

34/127 (26.8%)

118/329 (35.9%)

0.237

Phonophobia

147/456 (32.2%)

29/127 (22.8%)

118/329 (35.9%)

0.044

Avoidance of physical activity

289/432 (66.9%)

78/128 (60.9%)

211/304 (69.4%)

0.214

Worsening with physical activity

135/433 (31.2%)

36/128 (28.1%)

99/305 (32.5%)

0.626

Need for acute medication

413/437 (94.5%)

121/128 (94.5%)

292/309 (94.5%)

 > 0.999

  1. Significance level was adjusted after multiple comparisons with the False Discovery Rate (FDR) using the Benjamini–Hochberg procedure. In bold, statistically significant results. NRS Numeric Rating Scale.